Neuropsychiatric EEG-Based Assessment Aid regulatory update

FDA approved the Neuropsychiatric EEG-Based Assessment Aid (NEBA) System from NEBA Health to assist in diagnosing ADHD in patients ages 6-17 years in combination with a complete medical and psychologi...